Antibiotic use is associated with SJ syndrome and toxic epidermal necrosis, with sulfonamides being the most common culprits.

Published Date: 17 Feb 2023

Antibiotic use linked to SJ syndrome and toxic epidermal necrosis, sulfonamides are worst culprits in new study...

Read Full News

Latest News

Topical Roflumilast Approved for Psoriasis Down to Age 2

Safety and efficacy data in younger children were consistent with data in adolescent and adult studies.

US DOJ Closes Criminal Probe Into Abbott Over Baby Formula Plant, WSJ Reports

The U.S. Justice Department closed a criminal probe into Abbott Laboratories over its handling of a baby formula ⁠plant linked to potentially deadly bacteria and infant...

FDA Approves Risankizumab for Children With Psoriasis, PsA

The interleukin 23 inhibitor was approved for treating moderate-to-severe plaque psoriasis in adults in 2019 and for active psoriatic arthritis in adults in 2022.

Tattooed Skin: A Novel SSI Risk Factor in Spine Surgery

Tattooed skin at the operative site nearly triples the risk for surgical site infections in spine surgery, demanding individualised perioperative protocols.

Can Bimekizumab Match IL-23 Inhibitors in Psoriasis?

A retrospective study finds that bimekizumab yields comparable drug survival to interleukin-23 inhibitors after the failure of interleukin-17 inhibitors in patients with psoriasis.

Traveling in Europe: Should Mosquito Risks Be on Your Radar?

Travel medicine specialists say that mosquito protection deserves the same attention as sunscreen because vector-borne infections become more common in Europe.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Latest News

Safety and efficacy data in younger children were consistent with data in adolescent and adult studies.

The U.S. Justice Department closed a criminal probe into Abbott Laboratories over its handling of a baby formula ⁠plant linked to potentially deadly bacteria and infant...

The interleukin 23 inhibitor was approved for treating moderate-to-severe plaque psoriasis in adults in 2019 and for active psoriatic arthritis in adults in 2022.

Tattooed skin at the operative site nearly triples the risk for surgical site infections in spine surgery, demanding individualised perioperative protocols.

A retrospective study finds that bimekizumab yields comparable drug survival to interleukin-23 inhibitors after the failure of interleukin-17 inhibitors in patients with psoriasis.

Travel medicine specialists say that mosquito protection deserves the same attention as sunscreen because vector-borne infections become more common in Europe.

News All Time

How Blood Transfusion Became Safer

A practice once driven by hopes of restoring life and vitality is now a high-precision therapy where every unit of blood must be matched, tested, and traced.

Are Drug‑Resistant Infections Outpacing Industry Efforts?

High-quality research and proper antimicrobial stewardship can hold the key to mitigating antibiotic resistance.

Vulvar Melanoma Outcomes Worse With Surgery Delay

Surgical delays of 91 days and longer from diagnostic biopsy are linked to positive margins and worse survival in patients with early-stage vulvar melanoma, study finds.

Elicio Shares Slide After Pancreatic Cancer Vaccine Falls Short in Mid-stage Study

Elicio Therapeutics shares fell about 72% on Monday after the biotech firm's experimental pancreatic cancer vaccine ⁠failed to significantly extend the time patients lived...

Social Media Sunscreen Recipes Raise Safety Concerns

Homemade sunscreen recipes are gaining attention, but laboratory studies suggest they may reduce ultraviolet damage unevenly and fail against key sunburn markers.

Cutaneous Lupus Flares Peak During Late Perimenopause

Cutaneous lupus flares increase during late perimenopause and remain elevated after menopause, study finds.

Somatic Cancer Symptoms May Be Overattributed to Depression

Experts offer advice for treating symptoms of ovarian, breast, and other cancers that are not driven by depression and explain why it’s essential to discern the difference.

UKHSA: New Pandemic More Than 25% Likely Within 5 Years

Influenza and novel coronavirus top a new UKHSA threat register covering 22 risks, from dengue to drug-resistant infections.

Most OTC Vaginal Moisturizers Contain Contact Allergens

Over-the-counter vaginal and vulvar moisturizers often contain allergens, with inaccurate marketing claims, a study shows.

Drop Flare Fears to Fix Rheumatic Vaccination Gaps

Vaccination remains the best measure to protect immunosuppressed patients, but new evidence suggests a rethink of scheduling.

Secondary Syphilis Sign Shows Reliable Histologic Pattern

Condyloma lata in secondary syphilis shows consistent histopathologic findings that may help prevent misdiagnosis.

Takeda's AI-crafted Psoriasis Pill Tops Bristol Myers' Sotyktu in Head-to-head Trial

Japan's Takeda Pharmaceutical said on Thursday its experimental once-daily psoriasis pill, developed with the help of AI, outperformed Bristol ⁠Myers Squibb's approved drug...

Can Age-Old Chinese Therapy Reduce Insulin Needs in T2D?

Acupuncture may reduce insulin requirements to a greater extent than a sham treatment in adults with type 2 diabetes and overweight receiving insulin therapy, a trial suggests.

Psoriasis in Pregnancy: Study Supports Safety of Biologics

In pregnant women with psoriasis, biologic therapy is not linked to increased risk for adverse maternal or neonatal outcomes compared with unexposed patients, study finds.

Golimumab Shows Benefit in Refractory HS

More than half of patients with treatment-refractory hidradenitis suppurativa achieve meaningful disease improvement with golimumab therapy in a study.

How Can Canada Improve Access to Dermatologic Care?

The Canadian Dermatology Association proposes increasing residency spots, expanding technology, and integrating international graduates into the workforce.

Recommended News For You

Metastatic breast cancer can be effectively treated with cyclical estrogen and anti-estrogen therapy.

Enhanced CAR T cell therapy offers new strategy for lymphoma

Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa

Adding cell-based vaccine to liver cancer therapy can slow cancer progression

Males with early-onset colorectal cancer are at risk, according to a study.

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

Q&A: When will individuals be able to receive customized cancer vaccines?

Recommended Articles For You

Strategic Practices in Oncology for Specialists 

A Comprehensive Guide To Understanding Plasma Osmolality 

Revolutionizing Cancer Care: The Impact of Darzalex Faspro 

Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

2.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

3.

Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study

4.

Providing essential cancer care to rural communities

5.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

1.

What You Need to Know about Hairy Cell Leukemia: A Comprehensive Guide 

2.

Practical Solutions in Oncology and Patient Outcomes

3.

Exploring the Use of Bevacizumab in Treating Different Types of Cancers 

4.

Hematopoietic Niche Reconditioning Strategies in Blood Disorders

5.

Liquid Biopsies Unveiling the Future of Precision Cancer Management by 2025

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

2.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

3.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

4.

Navigating the Complexities of Ph Negative ALL - Part VIII

5.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot